Patents Assigned to INTERIUS BIOTHERAPEUTICS, INC.
  • Pseudotyped viral particles, compositions comprising the same, and uses thereof
    Patent number: 11767366
    Abstract: Provided for herein are mutant VSV-G polypeptides, compositions comprising the same, and methods of using the same. Also provided for herein are polypeptides and compositions that bind to CD7 and uses thereof. Also provided for herein are polypeptides and compositions that bind to CD8 and uses thereof.
    Type: Grant
    Filed: December 15, 2022
    Date of Patent: September 26, 2023
    Assignee: INTERIUS BIOTHERAPEUTICS, INC.
    Inventors: Ronnie M. Russell, Philip R. Johnson